✦ LIBER ✦

The female superiority in survival in clinical stage. II. Cutaneous malignant melanoma

✍ Scribed by H. M. Shaw; V. J. McGovern; G. W. Milton; G. A. Farago; W. H. McCarthy

Publisher: John Wiley and Sons
Year: 1982
Tongue: English
Weight: 343 KB
Volume: 49
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19820501)49:9<1941::aid-cncr2820490932>3.0.co;2-v

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Histologic features of tumors and the fe

Histologic features of tumors and the female superiority in survival from malignant melanoma

✍ H. M. Shaw; V. J. McGovern; G. W. Milton; G. A. Farago; W. H. McCarthy 📂 Article 📅 1980 🏛 John Wiley and Sons 🌐 English ⚖ 423 KB 👁 1 views

Malignant melanoma: Influence of site of

Malignant melanoma: Influence of site of lesion and age of patient in the female superiority in survival

✍ H. M. Shaw; V. J. McGovern; G. W. Milton; G. A. Farago; W. H. McCarthy 📂 Article 📅 1980 🏛 John Wiley and Sons 🌐 English ⚖ 442 KB 👁 1 views

Efforts were made to further explain female superiority in survival of 753 patients with clinical Stage I malignant melanoma. Two factors contributing to this female superiority in survival drew some of their prognostic value from the correlation with tumor thickness. (1) More than twice as many wom

Sex differences in presentation of cutan

Sex differences in presentation of cutaneous malignant melanoma and in survival from stage I disease

✍ Conor J. O'Doherty; Robin J. Frescott; Hugh White; Margaret McIntyre; John A. A. 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 English ⚖ 423 KB 👁 2 views

The sentinel lymph node status is an imp

The sentinel lymph node status is an important factor for predicting clinical outcome in patients with Stage I or II cutaneous melanoma

✍ Markwin G. Statius Muller; Paul A. M. van Leeuwen; Elly S. M de Lange-de Klerk; 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 93 KB 👁 1 views

Malignant melanoma of the vulva in a nat

Malignant melanoma of the vulva in a nationwide, 25-year study of 219 Swedish females : Predictors of survival

✍ Boel K. Ragnarsson-Olding; Bo R. Nilsson; Lena R. Kanter-Lewensohn; Bengt Lagerl 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 129 KB

## BACKGROUND. In an epidemiologic study of 219 Swedish females with vulvar melanoma, the authors previously established the incidence of this disease as 0.19 per 100,000 women, with a 3% annual decrease from 1960 to 1984 and a 5-year relative survival rate of 47%. After reviewing the medical histo

Loss of expression of the p16INK4/CDKN2

Loss of expression of the p16INK4/CDKN2 gene in cutaneous malignant melanoma correlates with tumor cell proliferation and invasive stage

✍ Lauri Talve; Ilari Sauroja; Yrjö Collan; Kari Punnonen; Tauno Ekfors 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 French ⚖ 155 KB 👁 2 views

The G 1 /S checkpoint of the cell cycle is regulated by p16, p53 and RB tumor suppressor genes. Loss of expression of the p16 INK4 tumor suppressor protein, the product of the CDKN2 gene, has been associated with a wide variety of human malignancies. Mutations, loss of heterozygosity and deletions o